Clinical Trial Update: Open-label Study of DS-8273a to Assess Its Safety and Tolerability, and Assess Its Pharmacokinetic and Pharmacodynamic Properties in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1]

View source ↗

Summary

This update reports the completion of an open-label Phase 1 trial of DS-8273a in subjects with advanced solid tumors or lymphomas, assessing safety, tolerabilit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• DS-8273a

Snippet

Sponsor: Daiichi Sankyo | Conditions: Advanced Solid Tumor, Lymphoma | Phase 1 | Status: COMPLETED